glp-1 pfizer Pfizer's Berobenatide: A Once-Monthly Peptide Moves Toward Phase 3 Danuglipron: An Oral GLP-1R Agonist
Description
Nowhere is this tension more visible than in the UK
Alcohol, liver disease and the gut microbiota
As both a GLP-1 and GIP agonist, Tirzepatide enhances weight loss effects beyond GLP-1-only therapy
Many people choose after breakfast
The success of injection-based GLP-1s in changing metabolic care may push some PBMs to ease access over time (if they see long-term healthcare savings)
